Clover Health Investments Corp (NASDAQ: CLOV) kicked off on Friday, up 3.67% from the previous trading day, before settling in for the closing price of $3.00. Over the past 52 weeks, CLOV has traded in a range of $0.61-$4.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 52.25%. While this was happening, its average annual earnings per share was recorded 73.31%. With a float of $377.31 million, this company’s outstanding shares have now reached $394.44 million.
Considering the fact that the conglomerate employs 552 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.71%, while institutional ownership is 16.39%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Take a look at Clover Health Investments Corp’s (CLOV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Compared to the last year’s volume of 7.79 million, its volume of 4.2 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 12.61%. Additionally, its Average True Range was 0.17.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 50.16%, which indicates a significant increase from 26.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.55% in the past 14 days, which was lower than the 93.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.66, while its 200-day Moving Average is $2.06. Nevertheless, the first resistance level for the watch stands at $3.16 in the near term. At $3.22, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.31. If the price goes on to break the first support level at $3.01, it is likely to go to the next support level at $2.92. Now, if the price goes above the second support level, the third support stands at $2.86.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
The company with the Market Capitalisation of 1.62 billion has total of 501,109K Shares Outstanding. Its annual sales at the moment are 2,034 M in contrast with the sum of -213,360 K annual income. Company’s last quarter sales were recorded 330,990 K and last quarter income was -9,160 K.
